222 related articles for article (PubMed ID: 15310983)
41. Prognostic implication of capsular invasion without perinephric fat infiltration in localized renal cell carcinoma.
Jeong IG; Jeong CW; Hong SK; Kwak C; Lee E; Lee SE
Urology; 2006 Apr; 67(4):709-12. PubMed ID: 16566981
[TBL] [Abstract][Full Text] [Related]
42. How do symptoms have an impact on the prognosis of renal cell carcinoma?
Kawata N; Nagane Y; Yamaguchi K; Ichinose T; Hirakata H; Takahashi S
Int J Urol; 2008 Apr; 15(4):299-303. PubMed ID: 18380815
[TBL] [Abstract][Full Text] [Related]
43. Proposal for reclassification of the TNM staging system in patients with locally advanced (pT3-4) renal cell carcinoma according to the cancer-related outcome.
Ficarra V; Novara G; Iafrate M; Cappellaro L; Bratti E; Zattoni F; Artibani W
Eur Urol; 2007 Mar; 51(3):722-9; discussion 729-31. PubMed ID: 16904819
[TBL] [Abstract][Full Text] [Related]
44. Prognostic value of microscopic venous invasion in renal cell carcinoma: long-term follow-up.
Lang H; Lindner V; Letourneux H; Martin M; Saussine C; Jacqmin D
Eur Urol; 2004 Sep; 46(3):331-5. PubMed ID: 15306103
[TBL] [Abstract][Full Text] [Related]
45. Original and reviewed nuclear grading according to the Fuhrman system: a multivariate analysis of 388 patients with conventional renal cell carcinoma.
Ficarra V; Martignoni G; Maffei N; Brunelli M; Novara G; Zanolla L; Pea M; Artibani W
Cancer; 2005 Jan; 103(1):68-75. PubMed ID: 15573369
[TBL] [Abstract][Full Text] [Related]
46. Reevaluation of TNM staging of renal cortical tumors: recurrence and survival for T1N0M0 and T3aN0M0 tumors are equivalent.
Gilbert SM; Murphy AM; Katz AE; Goluboff ET; Sawczuk IS; Olsson CA; Benson MC; McKiernan JM
Urology; 2006 Aug; 68(2):287-91. PubMed ID: 16904438
[TBL] [Abstract][Full Text] [Related]
47. Prognostic relevance of tumour size in T3a renal cell carcinoma: a multicentre experience.
Lam JS; Klatte T; Patard JJ; Goel RH; Guillè F; Lobel B; Abbou CC; De La Taille A; Tostain J; Cindolo L; Altieri V; Ficarra V; Artibani W; Prayer-Galetti T; Schips L; Zigeuner R; Pantuck AJ; Figlin RA; Belldegrun AS
Eur Urol; 2007 Jul; 52(1):155-62. PubMed ID: 17316970
[TBL] [Abstract][Full Text] [Related]
48. Relationship between age at diagnosis and clinicopathologic features of renal cell carcinoma.
Verhoest G; Veillard D; Guillé F; De La Taille A; Salomon L; Abbou CC; Valéri A; Lechevallier E; Descotes JL; Lang H; Jacqmin D; Tostain J; Cindolo L; Ficarra V; Artibani W; Schips L; Zigeuner R; Mulders PF; Mejean A; Patard JJ
Eur Urol; 2007 May; 51(5):1298-304; discussion 1304-5. PubMed ID: 17174023
[TBL] [Abstract][Full Text] [Related]
49. A novel tumor grading scheme for chromophobe renal cell carcinoma: prognostic utility and comparison with Fuhrman nuclear grade.
Paner GP; Amin MB; Alvarado-Cabrero I; Young AN; Stricker HJ; Moch H; Lyles RH
Am J Surg Pathol; 2010 Sep; 34(9):1233-40. PubMed ID: 20679882
[TBL] [Abstract][Full Text] [Related]
50. Preoperative prognostic nomogram (probability table) for renal cell carcinoma based on TNM classification.
Kanao K; Mizuno R; Kikuchi E; Miyajima A; Nakagawa K; Ohigashi T; Nakashima J; Oya M
J Urol; 2009 Feb; 181(2):480-5; discussion 485. PubMed ID: 19100568
[TBL] [Abstract][Full Text] [Related]
51. [Impact of tumor size on long-term survival of patients with organ-confined renal cell cancer].
Merseburger AS; Wegener G; Horstmann M; Oelke M; Zumbrägel A; Bokemeyer C; Kollmannsberger C; Jonas U; Stenzl A; Kuczyk M
Aktuelle Urol; 2003 Dec; 34(7):469-74. PubMed ID: 14655083
[TBL] [Abstract][Full Text] [Related]
52. Impact of several histopathological prognosticators and local tumour extension on oncological outcome in pT3b/c N0M0 renal cell carcinoma.
Roos FC; Weirich J; Victor A; Elsässer A; Brenner W; Biesterfeld S; Hampel C; Thüroff JW
BJU Int; 2009 Aug; 104(4):461-9. PubMed ID: 19338563
[TBL] [Abstract][Full Text] [Related]
53. Reappraisal of T3N0/NxM0 renal cell carcinoma: significance of extent of fat invasion, renal vein invasion, and adrenal invasion.
Jung SJ; Ro JY; Truong LD; Ayala AG; Shen SS
Hum Pathol; 2008 Nov; 39(11):1689-94. PubMed ID: 18656240
[TBL] [Abstract][Full Text] [Related]
54. Morphological subtyping of papillary renal cell carcinoma: clinicopathological characteristics and prognosis.
Yamashita S; Ioritani N; Oikawa K; Aizawa M; Endoh M; Arai Y
Int J Urol; 2007 Aug; 14(8):679-83. PubMed ID: 17681054
[TBL] [Abstract][Full Text] [Related]
55. The prognostic value of erythrocyte polyamine in the post-nephrectomy stratification of renal cell carcinoma specific mortality.
Bigot P; Lughezzani G; Karakiewicz P; Perrotte P; Rioux-Leclercq N; Catros-Quemener V; Bouet F; Moulinoux JP; Cipolla B; Patard JJ
J Urol; 2010 Feb; 183(2):486-91. PubMed ID: 20006872
[TBL] [Abstract][Full Text] [Related]
56. Young age is independent prognostic factor for cancer-specific survival of low-stage clear cell renal cell carcinoma.
Jung EJ; Lee HJ; Kwak C; Ku JH; Moon KC
Urology; 2009 Jan; 73(1):137-41. PubMed ID: 18950844
[TBL] [Abstract][Full Text] [Related]
57. CD44 is an independent prognostic factor in conventional renal cell carcinomas.
Paradis V; Ferlicot S; Ghannam E; Zeimoura L; Blanchet P; Eschwége P; Jardin A; Benoît G; Bedossa P
J Urol; 1999 Jun; 161(6):1984-7. PubMed ID: 10332486
[TBL] [Abstract][Full Text] [Related]
58. Cancer specific survival for patients with pT3 renal cell carcinoma-can the 2002 primary tumor classification be improved?
Leibovich BC; Cheville JC; Lohse CM; Zincke H; Kwon ED; Frank I; Thompson RH; Blute ML
J Urol; 2005 Mar; 173(3):716-9. PubMed ID: 15711250
[TBL] [Abstract][Full Text] [Related]
59. Prognostic factors for the survival of patients with papillary renal cell carcinoma: meaning of histological typing and multifocality.
Mejean A; Hopirtean V; Bazin JP; Larousserie F; Benoit H; Chrétien Y; Thiounn N; Dufour B
J Urol; 2003 Sep; 170(3):764-7. PubMed ID: 12913693
[TBL] [Abstract][Full Text] [Related]
60. The expression of thrombospondin-1 and p53 in clear cell renal cell carcinoma: its relationship to angiogenesis, cell proliferation and cancer specific survival.
Zubac DP; Bostad L; Kihl B; Seidal T; Wentzel-Larsen T; Haukaas SA
J Urol; 2009 Nov; 182(5):2144-9. PubMed ID: 19758660
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
